Driving Ability of Drug Dependant Patients in Maintenance Therapy
NCT ID: NCT01150435
Last Updated: 2010-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
121 participants
OBSERVATIONAL
2008-02-29
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subject of this study was to verify if patients under substitution therapy with R, S- Methadone, S- Methadone, Buprenorphine and Buprenorphine plus Naloxone are just as fit to drive a car as a non drug dependent person.
For this investigation we compared 121 drug dependent patients in stable maintenance therapy for a minimum of two years without consumption of any other psychotropic substances than their maintenance drug (including THC) with non- drug dependant subjects of the same gender, age and level of education.
This is the largest study on this topic worldwide. The neuro- cognitive working order was tested by means of the "Vienna Test System" an objective, reliable and valid test quantifying reaction time, attention efficiency, concentration, maximum resilience and orientation. Current use of any other psychotropic substance or alcohol just as any serious illness (including psychiatric diseases, except for an effectively treated depression) lead to exclusion from this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
NCT04178993
Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.
NCT00189059
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942
Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
NCT01057329
The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine Dependents
NCT03748875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Maintenance Medication D, S- Methadon
No interventions assigned to this group
Maintenance Medication S- Methadon
No interventions assigned to this group
Buprenorphine
No interventions assigned to this group
Buprenorphine+ Naloxone
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written agreement on attending this study after full clarification
* majority
Exclusion Criteria
* Patients, who are not legally competent
* Patients in emergency situations
* Patients under age
* Consumption of any other psychotropic substances than the maintenance drug
* Severe illnesses p.e. malignant diseases, serious psychiatric illness
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Hummel, Christiane
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christiane Hummel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Gilg, Proffessor
Role: STUDY_DIRECTOR
Institut für Rechtsmedizin München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut für Rechtsmedizin
Munich, Baveria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hummel 2010-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.